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Immunity to Mycobacterium tuberculosis in humans
and in mice requires interferon gamma (IFN-g).
Whereas IFN-g has been studied extensively for its
effects on macrophages in tuberculosis, we deter-
mined that protective immunity to tuberculosis also
requires IFN-g-responsive nonhematopoietic cells.
Bonemarrowchimericmicewith IFN-g-unresponsive
lung epithelial and endothelial cells exhibited earlier
mortality and higher bacterial burdens than control
mice, underexpressed indoleamine-2,3-dioxygenase
(Ido1) in lung endothelium and epithelium, and over-
expressed interleukin-17 (IL-17) withmassive neutro-
philic inflammation in the lungs. We also found that
the products of IDO catabolism of tryptophan
selectively inhibit IL-17 production by Th17 cells, by
inhibiting the action of IL-23. These results reveal
a previously unsuspected role for IFN-g responsive-
ness in nonhematopoietic cells in regulation of immu-
nity toM. tuberculosis and illustrate the role of IDO in
the inhibition of Th17 cell responses.
INTRODUCTION
Interferon gamma (IFN-g) is essential to restrict progressive, fatal
infection with Mycobacterium tuberculosis. Patients that are
either deficient in IFN-g (Fieschi et al., 2003) or are incapable
of responding to IFN-g because of mutations in IFN-gR1 or
IFN-gR2 suffer severe tuberculosis (Jouanguy et al., 1997), as
well as infections with less virulent species of mycobacteria
(Filipe-Santos et al., 2006). Likewise, IFN-g-deficient mice
infected with M. tuberculosis die rapidly with high bacterial
burdens in the lungs (Cooper et al., 1993; Flynn et al., 1993),
implying that IFN-g contributes to the restriction of bacterial
growth. Efforts to understand the actions of IFN-g that contribute
to restriction and/or killing ofM. tuberculosis have been confined
to studies of macrophages because these cells are known to
harbor the bacteria in vivo and because IFN-g was originally
characterized as amacrophage-activating factor (Nathan, 1983).
Subsequent studies have revealed essential roles for IFN-g-974 Immunity 31, 974–985, December 18, 2009 ª2009 Elsevier Inc.responsive genes such as Nos2 (MacMicking et al., 1997) and
lrgm1 (MacMicking et al., 2003), which provide nonoverlapping
functions that restrict M. tuberculosis in cultured macrophages
and in mice. In addition, IFN-g treatment of cultured macro-
phages has been shown to promote acidification of mycobacte-
rial phagosomes (Schaible et al., 1998) and autophagy, which
can result in limited intracellular killing ofM. tuberculosis (Gutier-
rez et al., 2004). Whereas these studies have advanced our
knowledge of the roles of IFN-g in the control of tuberculosis
by immune cells, a comprehensive understanding of the contri-
bution of IFN-g to immunity to M. tuberculosis is still lacking.
Because M. tuberculosis infection of cultured macrophages
inhibits IFN-g induction of selected genes (Banaiee et al.,
2006; Nagabhushanam et al., 2003; Ting et al., 1999), and
because IFN-gR and the molecules of the JAK-STAT pathway,
required for IFN-g signaling, are expressed in diverse cell types,
including nonhematopoietic cells such as epithelial and endo-
thelial cells and fibroblasts (Schroder et al., 2004), we hypothe-
sized that control of M. tuberculosis also requires responses to
IFN-g by nonhematopoietic cells. To test this hypothesis, we
used IFN-gR1-deficient and wild-type mice to prepare bone
marrow chimeric mice whose hematopoietic and nonhemato-
poietic cells were selectively incapable of responding to IFN-g.
We confirmed that early control of M. tuberculosis infection
requires IFN-g-responsive hematopoietic cells; we found that
long-term control of tuberculosis also requires IFN-g-responsive
nonhematopoietic cells. In the absence of IFN-gR1 on nonhema-
topoietic cells, mice succumbed to M. tuberculosis infection,
with severe inflammation in the lungs. Expression of IFN-g-
responsive genes and immunohistochemical analyses revealed
that IFN-gR1-deficient nonhematopoietic cells under-expressed
indoleamine-2,3-dioxygenase in lung epithelium and endothe-
lium during chronic tuberculosis, and this was accompanied by
overexpression of IL-17 and massive recruitment of neutrophils
to the lungs. These results extend the previously published
observation that control of an intracellular pathogen requires
IFN-g-responsive hematopoietic and nonhematopoietic cells
when the pathogen invades both cell types (e.g., Toxoplasma
gondii) (Yap and Sher, 1999). We thus showed that IFN-g-
responsive nonhematopoietic cells are also required for control
of M. tuberculosis, which, unlike T. gondii, resides predomi-
nantly, if not exclusively, in hematopoietic cells such as macro-
phages, dendritic cells, and neutrophils (Wolf et al., 2007).
Figure 1. Control of Long-TermM. tubercu-
losis Infection Is Impaired in the Absence of
IFN-gR1 on Nonhematopoietic Cells
(A) Survival of chimeric mice after infection with
M. tuberculosis: W/W (n = 5), W/K (n = 15),
K/W (n = 15), and K/K (n = 10). Data are
representative of three independent experiments.
Groups were compared with a log rank test.
(B) Bacterial load in the lungs of infected chimeric
mice as evaluated by plating serial dilutions of lung
homogenates on 7H11 agar. Data are representa-
tive of three independent experiments and
expressed as the mean (±SE) of four mice per
time point and per group. Groups were compared
with unpaired Student’s t test with a 95% confi-
dence interval. **p < 0.01, ***p < 0.005. Bacterial
loads in the lungs of the respective groups of
chimeric mice 3 and 4 weeks postinfection are
presented in Figure S2A.
(C) Lung histopathology in W/W andW/Kmice
14 weeks after infection withM. tuberculosis. Lung
left lobes were fixed in paraformaldehyde for a
minimum of 7 days. Histopathology was analyzed
by hematoxylin and eosin (H&E) staining of para-
formaldehyde-fixed paraffin-embedded 5 mm
tissue sections 14 weeks after aerosol infection
with M. tuberculosis. The image is shown at 403
the original magnification.
(D) Neutrophils (arrowhead) infiltrating the lungs
of W/K mice as evidenced by H&E staining
14 weeks post-infection. The image is shown at
4003 the original magnification. The inset is
shown at 10003 magnification.
(E) Kinyoun’s acid-fast staining with brilliant green
counterstaining showing neutrophils infected with
M. tuberculosis (arrowheads) in the lungs of W/K
mice 14 weeks after infection. The image is shown
at 4003 the original magnification. The inset is
shown at 10003 magnification.
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parenchymal cells in regulation of immune responses, especially
in the context of infection with persistent pathogens such as
M. tuberculosis.
RESULTS
Immune Control of Tuberculosis Requires
IFN-g-Responsive Nonhematopoietic Cells
To test the hypothesis that IFN-g contributes to immune control
of tuberculosis by effects on cells other than macrophages, we
examined the consequences of the absence of IFN-g respon-
siveness in hematopoietic versus nonhematopoietic cells on
survival and pathology after a low-dose aerosol infection of
mice with M. tuberculosis.Immunity 31, 974–985, DWe found that chimeric mice reconsti-
tuted with Ifngr1/ bone marrow cells
died soon after infection, regardless
of the presence of IFN-gR1 on nonhema-
topoietic cells (Figure 1A). Remark-
ably, wild-type mice reconstituted with
Ifngr1/ bone marrow (K/W mice)
died significantly earlier than Ifngr1/ mice reconstituted with
Ifngr1/ bone marrow (K/K mice) (median survival = 5.4 ±
0.2 weeks versus 5.9 ± 0.3 weeks, p < 0.05; Figure 1A). The
earlier death of K/W mice was accompanied by higher bacte-
rial burdens in the lungs than in K/K mice as measured
3 weeks (6.4 ± 0.1 versus 7.2 ± 0.1 log10; p = 0.0018; Fig-
ure 1B and Figure S2A available online) and 4 weeks postinfec-
tion (8.5 ± 0.1 versus 7.4 ± 0.2 log10; p = 0.0014; Figure 1B and
Figure S2A). The gross lung pathology of K/W mice was also
the most severe at that time (Figure S3A) and, although the
lesions appeared less extensive at the histological level than in
K/K mice, they were more multifocal (Figure S3C). These
results provide evidence that when hematopoietic cells,
including macrophages, are incapable of responding to IFN-g,
the response of nonhematopoietic cells to IFN-g is actuallyecember 18, 2009 ª2009 Elsevier Inc. 975
Figure 2. Cell Populations in the Lungs of IFN-gR Chimeric Mice
during M. tuberculosis Infection
(A) Total cell number in the lungs and their viability were assessed on single-
cell suspensions obtained from infected chimeric mice. Viability was higher
than 90%. Results are expressed as the mean number (±SE) of total cells
per lung and for four mice per time point and per group. Data were compared
with a two-tailed Student’s t test, *p < 0.05.
(B) Recruitment of neutrophils to the lungs of W/W and W/K mice during
infection withM. tuberculosis. Neutrophils were quantitated by flow cytometry
with single-cell suspensions stained with anti-CD11b and anti-Gr1. Results are
expressed as the average number (±SE) of CD11bhiGr1hi cells per lung and for
fourmice per time point and per group. Data were compared using a two-tailed
Student’s t test, *p < 0.05, **p < 0.01, and ***p < 0.005.
(C) Representative dot plots showing the proportion of CD11bhiGr1hi cells in
W/W and W/K mice 14 weeks after infection with M. tuberculosis.
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the lungs. Our observations in K/K and K/W mice also sub-
stantiate the long-held belief that macrophages need to respond
to IFN-g in order to control infection with M. tuberculosis.
In contrast to the mice whose hematopoietic cells were inca-
pable of responding to IFN-g, mice whose nonhematopoietic
cells were Ifngr1/ (W/K mice) survived the acute phase of
the infection (Figure 1A). They were no less capable of arresting
progressive growth of M. tuberculosis in the lungs 4 weeks
after infection than were mice with wild-type hematopoietic
and nonhematopoietic cells (W/W mice) (Figure 1B). In fact,
they had significantly fewer bacteria in their lungs at week 3
(p = 0.0445) and week 4 (p = 0.012) (Figure S2A). Both groups
also displayed small pulmonary lesions at that time (Figure S3).
However, the W/K mice succumbed earlier than the W/W
mice during the chronic phase of infection (median survival =
16.9 ± 1.1 weeks versus 27 ± 0.6 weeks, p < 0.001). All unin-
fected bone marrow chimeric mice survived for over 30 weeks,
indicating that death of the infected W/K mice was due to
M. tuberculosis. To assess the cause of death of the W/K
mice, we examined their ability to control growth ofM. tubercu-
losis and found that as the infection progressed beyond its
fourth week, M. tuberculosis continued to grow in the lungs of
W/K mice while the bacterial burden was maintained at
a plateau in W/W mice (Figure 1B). Consequently, the lung
bacterial load in W/K mice surpassed that in W/W mice
and by 14 weeks, as the mice of this group began to succumb,
the number of mycobacteria in the lungs reached 7.9 ±
0.2 log10, 1.4 log10 higher than in W/W mice at the same time
(p < 0.001). The W/K mice also had significantly higher bacte-
rial loads in the mediastinal lymph node (p < 0.01) (Figure S2B)
and the spleen (p < 0.01) (Figure S2C) on week 14 postinfection.
Gross pathologic examination of the lungs showed that W/W
mice had numerous focal subpleural lesions, whereas W/K
mice displayed no surface lesions (Figure S3B). Microscopic
examination revealed organized cellular aggregates limited to
the peripheral areas of the lungs in W/W mice, whereas the
entire pulmonary tissue of W/K mice was diffusely affected,
with a marked increase in cellularity (Figure 1C). Dense infiltrates
of polymorphonuclear granulocytes, most likely neutrophils,
were observed in the lungs of W/K mice (Figure 1D). In some
areas of the lungs, neutrophils andM. tuberculosis could be visu-
alized in close association (Figure 1E). Together, these observa-
tions indicate that the response to IFN-g in nonhematopoietic
cells plays an essential role in the control of M. tuberculosis
growth in the lungs after the acute phase of the infection.
Cell Recruitment to the Lungs of IFN-gR Bone Marrow
Chimeras Infected with M. tuberculosis
To determine whether the susceptibility of W/K mice was due
to defective activation and/or recruitment of immune cells to the
site of infection, we examined the cell populations in the lungs
during the course of infection.
The total number of cells did not differ significantly (p > 0.05)
between W/W and W/K mice for up to 9 weeks of infection
with M. tuberculosis (Figure 2A). During this phase, the number
of leukocytes in the lungs increased sharply in both groups,
peaked at 4 weeks postinfection then decreased progressively
until week 9. After week 9, the total number of cells remained976 Immunity 31, 974–985, December 18, 2009 ª2009 Elsevier Inc.unchanged in the lungs of W/W mice but increased signifi-
cantly (p = 0.0499) in W/K mice. Analysis of the T cell popula-
tions in the lungs of chimeric mice during infection revealed no
significant difference (p > 0.05) in CD4+ or CD8+ T cells between
the two groups of mice (Figure S4A). In both groups of mice, the
population of CD4+ T cells increased sharply after infection,
Figure 3. Differential Expression of IFN-g-Responsive
Genes in the Lungs of Chimeric Mice Infected with
M. tuberculosis for 9 Weeks
Microarray analysis was conducted on pools of RNA isolated from
four mice per group and the pools of each group were hybridized
against each other. The results are expressed as the fold change
in mRNA expression in W/K mice over W/W mice.
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chronic phase of infection. The number of CD8+ T cells also
increased upon M. tuberculosis infection, peaked at 4 weeks,
but experienced a smaller decline, without any plateau. As we
have previously reported (Wolf et al., 2008), CD4+ and CD8+
T cells also increased in number in the mediastinal (lung-drain-
ing) lymph node after infection; there was no significant differ-
ence (p > 0.05) in T cell expansion in the lymph node between
W/W and W/K mice (data not shown).
We (Wolf et al., 2007) and others (Gonzalez-Juarrero et al.,
2003; Skold and Behar, 2008) have shown that M. tuberculosis
induces the recruitment of several subsets of myeloid cells to
the lungs. When we compared populations of myeloid cells in
the lungs of M. tuberculosis-infected mice, we found that those
of W/K mice contained significantly (p < 0.05) fewer
CD11chiCD11bhi myeloid dendritic cells and CD11cloCD11bhi
inflammatory, interstitial macrophages during the early stages
of infection when compared to the lungs of W/W mice
(Figure S4B). The differences between the two groups of mice
diminished in the later stages of infection, when these myeloid
populations contracted in the W/Wmice. There was no signif-
icant difference (p > 0.05) between the two experimental groups
in the populations of CD11chiCD11blo alveolarmacrophages and
CD11cCD11bhiGr-1 monocytes. During the acute phase of
infection, CD11bhiGr-1hi granulocytes were more abundant in
lungs of W/K mice than in W/W mice (week 3: 5.0 ± 1.2 3
105 versus 1.8 ± 0.1 3 105 cells, p = 0.031), but by week 4, this
population contracted to the same level as in wild-type mice
(Figure 2B). At later time points, flow cytometry analysis
confirmed the microscopic findings (Figures 1D and 1E):
CD11bhiGr-1hi neutrophils were recruited to the lungs in large
numbers. By week 9, the abundance of granulocytes rose
sharply in the lungs of W/K mice, whereas it remained
unchanged in W/W mice (Figure 2B). At week 14, 2 weeks
prior to the average time of death, W/K mice had 30%
more cells in their lungs than W/W mice (1.6 ± 0.17 3 107
versus 1.2 ± 0.17 3 107 cells, p < 0.05), and CD11bhiGr-1hi
neutrophils fully accounted for this increase (Figures 2B and
2C). These results show that nonhematopoietic cells contribute
to the IFN-g-dependent recruitment of myeloid cells to the
lungs during M. tuberculosis infection.Immunity 31Differential Gene Expression in the Lungs of
IFN-gR Chimeric Mice during M. tuberculosis
Infection
To further understand the mechanisms underlying the
immune response to M. tuberculosis in W/K mice,
we compared gene expression profiles in the lungs
by using microarray analysis. We first focused our
attention on well-characterized IFN-g-responsivegenes (Ehrt et al., 2001; Sana et al., 2005). During the chronic
phase of infection, of the 20 IFN-g-responsive genes that we
selected and analyzed by microarray, 12 were not differentially
expressed between the two experimental groups (i.e., less
than 2-fold difference) and seven genes were significantly but
moderately (more than 2-fold but less than 10-fold difference)
underexpressed in the lungs of W/K mice in comparison to
those of W/W mice (Figure 3). Indoleamine 2,3-dioxygenase
(Ido1) was the only IFN-g-responsive gene that was underex-
pressed more than 10-fold: Ido1 mRNA expression was
29.4-fold greater (p = 5 3 1022) in the lungs of W/W mice in
comparison to W/K mice during week 9 postinfection.
To confirm these results with an unbiased set of genes, we
performed whole-genome expression profiling on the lungs of
infected chimeric mice. Of 41,171 genes analyzed, 1,761
were underexpressed and 1,894 genes were overexpressed
in W/K mice compared to W/Wmice during week 14 postin-
fection. A large fraction of the underexpressed genes are
involved in immune cell recruitment, B cell and NK cell functions,
and antigen presentation, whereas many of the overexpressed
genes have roles in tissue remodeling and inflammation
(Table 1). At 14 weeks postinfection, Ido1 remained the most
underexpressed gene in the lungs of W/K mice infected with
M. tuberculosis; its mRNA in W/W mice was expressed at
a level 36.6-fold higher than in the lungs of infected W/K
mice (p = 2.4 3 1022).
Differential Expression of Ido1 in IFN-gR Chimeric Mice
during M. tuberculosis Infection
To confirm the results obtained using whole-genome expression
profiling by microarray, we first quantified the specific expres-
sion of Ido1 mRNA by using quantitative real-time PCR during
the course of TB infection.
Ido1 mRNA expression was detected at very low and similar
amounts in the lungs of W/W and W/K mice after 2 weeks
of infection with M. tuberculosis (Figure 4A). One week later,
Ido1 expression rose sharply inW/Wmice andwasmaintained
throughout the infection, mirroring the expression of Ifng mRNA
in the lungs of these mice (Figure 4B). In contrast, Ido1 expres-
sion was reduced by 95% in the lungs of mice whose nonhema-
topoietic cells are unable to respond to IFN-g, even though the, 974–985, December 18, 2009 ª2009 Elsevier Inc. 977
Table 1. Selected Genes Under- or Overexpressed in the Lungs of W/KMice Compared to W/WMice 14Weeks after Infection with
M. tuberculosis
Name Sequence Description Accession Numbers Fold Change p Value
Stfa1 Stefin A1 NM_001001332 35.72946 3.00E-22
Glycam1 Glycosylation dependent cell adhesion molecule 1 NM_008134 28.69311 2.00E-20
Cxcl2 Chemokine (C-X-C motif) ligand 2 NM_009140 27.19208 6.00E-22
Camp Cathelicidin antimicrobial peptide NM_009921 16.35017 1.00E-20
Il17a Interleukin 17A NM_010552 14.32831 2.00E-20
Ccl3 Chemokine (C-C motif) ligand 3 NM_011337 8.84707 1.00E-18
Csf3 Colony stimulating factor 3 (granulocyte) NM_009971 6.82582 7.00E-16
Il1r2 Interleukin 1 receptor, type II NM_010555 6.37657 9.00E-17
Sele Selectin, endothelial cell NM_011345 5.48462 9.00E-14
Ccr1 Chemokine (C-C motif) receptor 1 NM_009912 4.77916 1.00E-06
Mmp9 Matrix metallopeptidase 9 NM_013599 3.95812 5.00E-34
Cxcl4 Chemokine (C-X-C motif) ligand 4 NM_019932 3.88045 7.00E-13
Cxcl5 Chemokine (C-X-C motif) ligand 5 NM_009141 3.76224 1.00E-12
Il23a Interleukin 23, alpha subunit p19 NM_031252 3.74914 4.00E-06
Il1b Interleukin 1 beta NM_008361 3.39765 3.00E-27
Il17f Interleukin 17F NM_145856 2.71424 1.00E-02
Irak2 Interleukin-1 receptor-associated kinase 2 NM_172161 2.66109 5.00E-09
Tnf Tumor necrosis factor NM_013693 2.60488 3.00E-17
Il6 Interleukin 6 NM_031168 2.56139 9.00E-17
Cxcl1 Chemokine (C-X-C motif) ligand 1 NM_008176 2.37728 9.00E-08
Col15a1 Procollagen, type XV NM_009928 2.37712 1.00E-07
Cd14 CD14 antigen NM_009841 2.35198 1.00E-07
Edn1 Endothelin 1 NM_010104 2.29886 2.00E-07
Tlr6 Toll-like receptor 6 NM_011604 2.1796 9.00E-07
Tlr4 Toll-like receptor 4 NM_021297 2.05686 2.00E-10
Psmb9 Proteosome subunit, beta type 9 NM_013585 2.01649 6.00E-06
Tbx21 T-box 21 NM_019507 2.02845 5.00E-06
Nox1 NADPH oxidase 1 NM_172203 2.04629 4.00E-01
Stat1 Signal transducer and activator of transcription 1 NM_009283 2.07716 3.00E-06
Tap1 Transporter 1, ATP-binding cassette, subfamily B NM_013683 2.12481 2.00E-06
Stat2 Signal transducer and activator of transcription 2 NM_019963 2.2154 6.00E-07
Card11 Caspase recruitment domain family, member 11 NM_175362 2.22414 5.00E-07
Cxcr3 Mus musculus chemokine (C-X-C motif) receptor 3 NM_009910 2.40445 7.00E-08
Lta Lymphotoxin A NM_010735 2.41145 7.00E-15
Ccr6 Chemokine (C-C motif) receptor 6 NM_009835 2.47999 3.00E-08
C2ta Class II transactivator NM_007575 2.51527 2.00E-08
Ifngr1 Interferon gamma receptor 1 NM_010511 2.63842 6.00E-09
Cd79a CD79A antigen (immunoglobulin-associated alpha) NM_007655 2.73226 3.00E-06
Gata3 GATA binding protein 3 NM_008091 2.73872 3.00E-09
Cd19 CD19 antigen NM_009844 2.88237 7.00E-10
Ighg Immunoglobulin heavy chain (gamma polypeptide) BC092269 3.15632 8.00E-11
H2-DMb2 Histocompatibility 2, class II, locus Mb2 NM_010388 3.18093 8.00E-11
Cd79b CD79B antigen NM_008339 3.3018 3.00E-11
Igtp Interferon gamma-induced GTPase NM_018738 3.44126 1.00E-11
Bank1 B cell scaffold protein with ankyrin repeats 1 NM_001033350 4.1653 3.00E-05
Cr2 Complement receptor 2 NM_007758 4.40919 8.00E-13
Klrb1c Killer cell lectin-like receptor subfamily B member 1C NM_008527 4.87152 3.00E-14
Igj Immunoglobulin joining chain NM_152839 5.08559 3.00E-15
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Table 1. Continued
Name Sequence Description Accession Numbers Fold Change p Value
Il22 Interleukin 22 NM_016971 5.74921 1.00E-06
Ido1 Indoleamine-pyrrole 2,3 dioxygenase 1 NM_008324 36.59276 2.00E-22
Microarray analysis was conducted on pools of RNA from five mice per group, and the pools of each group were hybridized against each other. The
results are expressed as the fold change in mRNA expression.
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week 3 of infection. These findings imply that IFN-g induces Ido1
expression by nonhematopoietic cells in the lungs during infec-
tion with M. tuberculosis and are consistent with reports that
IFN-g can induce Ido1 expression in cultured fibroblasts (Pfeffer-
korn et al., 1986) and epithelial cells (Rapoza et al., 1991). We
also confirmed that IFN-g treatment of cultured murine NIH/
3T3 fibroblasts induces expression of Ido1 (Figure S5).
We confirmed the underexpression of IDO at the protein level
by using immunohistochemistry. In the lungs of W/W mice
during the chronic phase of TB, airway epithelial cells and
vascular endothelial cells stained intensely with an antibody to
murine IDO. In addition, IDO expression was detected in cells
localized in granulomas that displayed the morphological char-
acteristics of macrophages and/or dendritic cells (Figure 4C).
In comparison, IDO staining in the lungs of W/Kmice 15 weeks
postinfection could only be detected in macrophages and/orIdendritic cells in granulomas, without any staining of epithelial
or endothelial cells (Figure 4C).
Taken together, these results provide strong evidence that
IFN-g-dependent expression of IDO in nonhematopoietic lung
cells contributes substantially to the overall expression of IDO
in the lungs of mice chronically infected with M. tuberculosis.
Mice with Ifngr1/ Nonhematopoietic Cells Develop
an Excessive IL-17 Response to M. tuberculosis
Whole-genome expression profiling of the lungs of chimericmice
chronically infected with M. tuberculosis also revealed overex-
pression of numerous genes involved in inflammation (Table 1).
Because we observed an exuberant inflammatory response,
including recruitment of neutrophils, during the chronic stage
of infection of W/K mice, we characterized the expression of
IL-17 in detail and analyzed the time course of Il17a expression
in the lungs of M. tuberculosis-infected mice by usingFigure 4. IFN-g-Dependent Expression of
IDO in Nonhematopoietic Cells Is Impaired
in the Lungs of W/K Mice Infected with
M. tuberculosis
(A and B) Quantitative real-time PCR (qRT-PCR)
evaluation of Ido1 (A) and Ifng (B) mRNA expres-
sion in the lungs of chimeric mice after infection
with M. tuberculosis. Results are expressed as
the average relative level of expression (±SE) of
specific mRNA after normalization to 18S ribo-
somal RNA for four mice per time point and per
group. Data were compared with a two-tailed
Student’s t test; *p < 0.05, **p < 0.01.
(C) Expression of IDO in lung sections of chimeric
mice 15 weeks after infection withM. tuberculosis.
Positive immunohistochemical staining in airway
epithelial (arrows), vascular endothelial (white
arrowheads), and myeloid (black arrowheads)
cells. The image is shown at 4003 the original
magnification.
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Figure 5. Il17a Expression during M. tuber-
culosis Infection In Vivo and Its Regulation
by Kynurenines In Vitro
(A) qRT-PCR evaluation of Il17a, Il23a, Tgfb1, and
Il6mRNA expression in the lungs of chimeric mice
after infection with M. tuberculosis. Results are
expressed as the average relative level of expres-
sion (±SE) of specific mRNA after normalization to
18S ribosomal RNA for four mice per time point
and per group. Il17a and Il23a mRNA expression
was quantitated 3, 4, 9, and 14 weeks after infec-
tion, and Tgfb1 and Il6 mRNA expression was
assayed on samples harvested on week 9 postin-
fection. Data were compared with a two-tailed
Student’s t test; *p < 0.05, **p < 0.01 or indicated
value.
(B) Dose response of IL-17 production by differen-
tiating Th17 cells in vitro in the presence of
increasing concentrations of tryptophan catabo-
lites (L-kynurenine, 30-hydroxy-DL-kynurenine,
30-hydroxyanthranilic acid, anthranilic acid, and
quinolinic acid). A nonlinear regression with vari-
able slope analysis was applied with Prism soft-
ware (GraphPad) so that an IC50 value of 11.7 ±
1.1 mM was determined.
(C) IL-17 production by differentiating Th17 cells
in vitro in the presence of 15 mM of tryptophan
catabolites after 6 days of culture, in the absence
of IL-23 (white bars), in the presence of IL-23 for
the last 3 days (gray bars), or for 6 days of culture
(black bars).
Each condition was assayed in triplicate. The
results are expressed as the mean concentration
(±SE) of IL-17 in the culture supernatants after
6 days of incubation as measured by ELISA and
are representative of two independent experi-
ments.
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Nonhematopoietic Response to IFN-g in TBquantitative real-time PCR. We also quantitated expression of
genes involved in the generation or maintenance of IL-17-
secreting cells, i.e., Il6, Tgfb1, and Il23a (Bettelli et al., 2007).
The expression of Il17a mRNA in the lungs of W/W and W/
K mice was low and equivalent until 4 weeks of infection with
M. tuberculosis (Figure 5A). By week 9 postinfection, less than
2 weeks before the W/K mice started to die, Il17a expression
increased more than 10-fold in the lungs of these mice but re-
mained at the same low amount in W/W mice. By 14 weeks
of infection, expression of Il17a in W/K mice was 163-fold
higher than in W/W mice.
Role of Kynurenines in Regulating Development
of Th17 Cells
Given that we observed marked underexpression of IDO in the
lungs of infected W/K mice, and that IDO catabolizes trypto-
phan to products (collectively termed kynurenines) with immuno-
regulatory properties (Munn and Mellor, 2007), we determined
whether defective generation of tryptophan catabolites might
account for the overexpression of Il17a in the lungs. First, we
examined the effects of tryptophan catabolites on the develop-
ment of Th17 cells in vitro.
An equimolar solution of L-kynurenine, 30-hydroxy-DL-kynure-
nine, 30-hydroxyanthranilic acid, anthranilic acid, and quinolinic
acid caused dose-dependent inhibition of IL-17 production by980 Immunity 31, 974–985, December 18, 2009 ª2009 Elsevier Inc.CD4+ T cells under Th17 cell-differentiating conditions, which
was detectable at a concentration of 7.5 mg/ml; complete inhibi-
tion was observed at a concentration of 25 mM for the mixture of
tryptophan catabolites (Figure 5B). In these conditions, nonlinear
regression analysis revealed an IC50 value of 11.7 ± 1.1 mM
(10.4 ± 1.1 mg/ml). When these compounds were tested individ-
ually, 30-hydroxyanthranilic acid was the most potent inhibitor of
IL-17 production, with an IC50 of 27.7 ± 3.7 mM, followed by
30-hydroxy-DL-kynurenine (IC50 = 68.1 ± 1.4 mM) and L-kynure-
nine (IC50 = 100.8 ± 1.0 mM) (Table 2). Anthranilic acid and
quinolinic acid had no inhibitory effect within the range of
concentrations assayed. The observation that the IC50 for the
mixture is lower than for any of the individual compounds
suggests that two or more of the individual compounds have
distinct targets that affect Th17 cell differentiation and/or IL-17
secretion. We found that kynurenines were able to inhibit IFN-g
production during Th1 cell differentiation but required substan-
tially higher concentrations (Table 2): the most potent inhibitor
was 30-hydroxyanthranilic acid, with an IC50 of 57.6 ± 1.0 mM.
The combination of catabolites did not reduce further the
production of IFN-g (IC50 = 57.9 ± 1.3 mM); therefore, the combi-
nation of tryptophan catabolites was 5-fold more potent for
inhibition of Th17 versus Th1 cell differentiation. In light of our
observation that W/K mice also exhibit poorer control of
M. tuberculosis growth late in infection (Figure 1B), we examined
Table 2. 30-Hydroxyanthranilic Acid Is the Most Potent
Tryptophan Catabolite for the Inhibition of IL-17 Production by
Th17 Cells In Vitro
IC50 (mM)
Tryptophan Metabolites Th1 Cells Th17 Cells
L-Kynurenine 154.5 ± 1.2 100.8 ± 1.0
30-Hydroxy-DL-kynurenine 153.8 ± 1.1 68.1 ± 1.4
30-Hydroxyanthranilic acid 57.6 ± 1.0 27.7 ± 3.7
Anthranilic acid No inhibition No inhibition
Quinolinic acid 111.5 ± 1.4 No inhibition
All 57.9 ± 1.3 11.7 ± 1.1
Inhibiting concentrations (IC50) of L-kynurenine, 3
0-hydroxy-DL-kynure-
nine, 30-hydroxyanthranilic acid, anthranilic acid, or quinolinic acid on
IFN-g and IL-17 production by differentiating Th1 and Th17 cells
in vitro, respectively. The results are expressed as the average IC50
values (±SE), calculated with a nonlinear regression with variable slope
(Prism software, GraphPad).
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in vitro (Figure S5). Although we found that kynurenines inhibited
growth of M. tuberculosis at concentrations previously reported
to inhibit growth of E. coli, the effective concentrations were
20-fold higher than the concentrations that inhibited Th17 cell
differentiation.
Because we also observed that IL-23p19 was overexpressed
in the lungs of M. tuberculosis-infected W/K mice, and
because IL-23 promotes development and maintenance of
Th17 cells in peripheral tissues as well as in lymph nodes
(McGeachy et al., 2009), we tested the hypothesis that trypto-
phan catabolites inhibit the action of IL-23 during Th17 cell differ-
entiation. We confirmed that IL-23 enhanced production of IL-17
under the conditions of our assay and found that tryptophan
catabolites completely abrogated the effect of IL-23, even
when they were only included during the latter stages of Th17
cell differentiation (Figure 5C). Taken together, these data indi-
cate that low concentrations of kynurenines are capable of
controlling the development of Th17 cells in vitro, in an IL-23-
dependent fashion.DISCUSSION
Whereas IFN-g is essential for immune control of M. tubercu-
losis, its targets and functions are still incompletely understood.
Because macrophages are a major cellular reservoir for
M. tuberculosis, previous studies have focused on the effects
of IFN-g on these cells, and Nos2 and Irgm1 are the only two
IFN-g-dependent macrophage effector genes known to be
essential for the control of tuberculosis (MacMicking et al.,
1997; MacMicking et al., 2003).
In the studies reported here, we provide the first direct
evidence that macrophages (and possibly other hematopoietic
cells) must be able to respond to IFN-g in vivo in order to control
growth ofM. tuberculosis. We also found that nonhematopoietic
cells must be responsive to IFN-g for durable control of bacterial
growth and survival of the host. One of themechanisms involving
IFN-g-responsive epithelial and endothelial cells is expression ofIIDO and regulation of IL-17 expression and neutrophilic inflam-
mation in the lungs.
During the acute stage of infection, the adaptive immune
response and its capacity to limit bacterial growth was unaf-
fected by the absence of IFN-gR on nonhematopoietic cells. In
accord with the observation that IFN-g induces expression of
CXCL9, CXCL10, and CXCL11 by cultured epithelial cells (Sauty
et al., 1999), we observed a transient deficit in expression of
these chemokines, but this had no effect on recruitment of
T cells to the lungs in W/K mice. The earliest detectable differ-
ence between M. tuberculosis-infected W/K and W/W mice
was a quantitative defect of lung myeloid dendritic cells and
interstitial macrophages. This defect, detectable byweek 3 post-
infection, could explain the lower bacterial burden in W/Kmice
at that time, given that reduced recruitment of target cells, such
as macrophages, can negatively influence the growth of myco-
bacteria (Davis and Ramakrishnan, 2009). However, by the ninth
week of infection, the number of recruited macrophages and
myeloid dendritic cells in the lungs was similar in both groups.
During the chronic stages of infection, W/K mice exhibited
poorer control of bacterial growth, overexpression of IL-17,
and neutrophilic inflammation in the lungs. These observations
could have at least two potential general explanations. One is
that nonhematopoietic cells are reservoirs of M. tuberculosis,
and IFN-g controls growth of bacteria in these cells. Despite
in vitro data showing that M. tuberculosis can be taken up by
cultured epithelial and endothelial cells (Bermudez and
Goodman, 1996; Debbabi et al., 2005; Mehta et al., 2006), and
some evidence that M. tuberculosis can be detected in lung
epithelial cells in experimental infections (Rivas-Santiago et al.,
2008; Teitelbaum et al., 1999), most evidence favors macro-
phages and dendritic cells as the cellular reservoirs forM. tuber-
culosis (Wolf et al., 2007). In our studies, acid-fast staining of the
lungs of W/K mice indicated that most of the bacteria were
associated with cells having the morphology of macrophages
and/or dendritic cells, and at later stages of infection, bacteria
were also associated with neutrophils. Therefore, the in vivo
significance of nonhematopoietic cells as reservoirs ofM. tuber-
culosis remains controversial and unlikely to explain our results.
Consequently, any IFN-g-inducible antimycobacterial activity
provided by nonhematopoietic cells would probably act through
secreted factors. Although nonhematopoietic cells can respond
to M. tuberculosis by secreting TNF, GM-CSF, and MCP-1
(CCL2) (Lin et al., 1998) and they can produce antimicrobial
products (Evans et al., 2009), few of these depend on IFN-g,
e.g., inducible nitric oxide synthase, b-defensins, NADPH
oxidases, and IDO. Among those, we found that Ido1 was the
most underexpressed IFN-g-responsive gene in W/K mice
during chronic TB and that epithelial and endothelial cells were
the major source of this enzyme at that time. IDO catalyzes the
first step of the degradation of tryptophan and is induced by
IFN-g in a wide variety of cells (Carlin et al., 1989). Its antimicro-
bial activity was originally attributed to tryptophan depletion
(Pfefferkorn, 1984); this is unlikely to account for our observa-
tions, given that M. tuberculosis can synthesize tryptophan
(Parish and Stoker, 2002). More recent data indicate that trypto-
phan catabolites generated by IDO, or kynurenines, possess
bacteriostatic activity (Narui et al., 2009), although we found
that inhibition of M. tuberculosis required kynureninemmunity 31, 974–985, December 18, 2009 ª2009 Elsevier Inc. 981
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that inhibit Th17 cell differentiation in vitro. Because macro-
phages and dendritic cells in both W/W and W/K mice can
respond to IFN-g and express IDO in vivo, it is unlikely that kynur-
enines mediate antimycobacterial activity strictly in an intracel-
lular environment. Other IFN-g-inducible molecules expressed
in nonhematopoietic cells and with a potential role in bacterio-
stasis include inducible nitric oxide synthase (NOS2) and b-de-
fensins. The expression profile of these genes did not suggest
any involvement in the mortality of infected W/K mice. Lastly,
expression of NADPH oxidase Nox1, also induced in nonhema-
topoietic cells by IFN-g and implicated in control of bacterial
infection (Leto and Geiszt, 2006; Robbins et al., 1994), was
only moderately reduced in W/K mice. The importance of
Nox1 in control ofM. tuberculosis is unknown, but mice deficient
in the related phagocyte NADPH oxidase Nox2 do not succumb
to TB (Nathan and Shiloh, 2000).
The second general mechanism that may account for the
death of W/K mice is dysregulation of the immune response
during chronic infection. Although IL-10 contributes to regulation
of immunity to TB during chronic infection (Higgins et al., 2009),
we did not observe any defect in IL-10 expression in infected
W/K mice. IDO has also been implicated in the regulation of
immune responses in several contexts (Brandacher et al.,
2008; Katz et al., 2008; Le and Broide, 2006; Zelante et al.,
2009). Much attention has been focused on IDO in regulatory
dendritic cells (Mellor and Munn, 2004) but nonhematopoietic
cells from human lung have been reported to regulate T cell
proliferation via IDO-dependent mechanisms in vitro (Heseler
et al., 2008). In our studies, Ido1 mRNA was detectable in the
lungs throughout infection with M. tuberculosis. However,
expression of the protein was limited to myeloid cells during
the acute phase (data not shown). Maximum IDO expression
appeared after 9 weeks of infection, in an IFN-gR-dependent
fashion and in airway epithelial cells and vascular endothelial
cells. This pattern suggests tissue-specific, posttranscriptional
regulation and may explain why IDO is only required during later
stages of infection. The observation that epithelial and endothe-
lial cells in W/K mice did not express detectable amounts of
IDO when IDO was readily detected in epithelial and endothelial
cells of W/W mice provides strong evidence that these cells
in the lungs were of recipient origin. This is consistent with the
observation that bone marrow cells do not differentiate into
lung epithelial cells at a detectable frequency (Kotton et al.,
2005).
Other important observations in chronically infected chimeric
mice were the dramatic increase in IL-17 expression, induction
of CXCL2, and a massive influx of neutrophils in the lungs, start-
ing at week 9 and peaking at week 14 of infection. The role of
IL-17 on neutrophil recruitment has been extensively studied
(Linden et al., 2005), but the relationship between M. tubercu-
losis infection and IL-17 has only been recently examined
(Khader and Cooper, 2008). Most evidence to date has indicated
a beneficial role for IL-17 in immunity to M. tuberculosis. In
particular, IL-17 is required for a protective memory response
after subunit vaccination (Khader et al., 2007). In addition,
gene delivery of IL-23 positively influences the outcome of
M. tuberculosis infection (Happel et al., 2005). One study showed
that infection of Ifng/ mice with BCG leads to increased982 Immunity 31, 974–985, December 18, 2009 ª2009 Elsevier Inc.frequency of IL-17-producing cells, but the investigators did
not report the outcome of this imbalance in terms of pathology
or bacterial control (Cruz et al., 2006). In our experiments, given
the timing and the amplitude of the neutrophilic inflammation
associated with the expression of IL-17 in infected W/K
mice, it is likely that overexpression of IL-17 contributes to the
death of W/K mice, through extensive tissue damage and
impaired respiratory function. Unchecked Th17 cell responses
have been associated with several inflammatory conditions. A
murine model of the severe inflammation observed in chronic
granulomatous disease (CGD) patients infected with Aspergillus
revealed an excessive IL-17 response provoked by the impaired
conversion of tryptophan into kynurenines (Romani et al., 2008).
In accordance with this observation, we found that individual
kynurenines have a direct and additive inhibitory effect on the
development of Th17 cells in vitro, at concentrations found
in vivo during viral pneumonia (Christen et al., 1990). This effect
on Th17 cell differentiation was selective, and at least in part
mediated by inhibition of the effects of IL-23; although kynure-
nines also inhibited Th1 differentiation, much higher concentra-
tions were required.
We therefore propose a model in which Ifngr1/ nonhemato-
poietic cells, unable to respond to IFNg during the chronic phase
of M. tuberculosis infection, fail to express the enzyme IDO and
to convert tryptophan to kynurenines. The ongoing bacterial
replication characterizing chronic TB in the murine model (Gill
et al., 2009) provides sustained proinflammatory signals which,
in the absence of kynurenines, triggers excessive production
of IL-17 and lethal lung neutrophilia.
Because the human response to infection withM. tuberculosis
can vary greatly, from asymptomatic latent infection to progres-
sive lung destruction with formation of pulmonary cavities and
extensive disability among survivors (de Valliere and Barker,
2004), evidence that defective expression of IDO in pulmonary
parenchymal cells, with overexpression of IL-17 and excessive
inflammation contributes to fatal infection in mice, provides an
incentive to determine whether these mechanisms contribute
to morbidity and mortality in humans with tuberculosis.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 congenic CD45.1+wild-type (W) andCD45.2+ Ifngr1/ (K) micewere
originally purchased from The Jackson Laboratory (Bar Harbor, ME). They
were bred as homozygotes and maintained under specific pathogen-free
conditions at the New York University Medical Center (NYUMC, New York,
NY). For infections withMycobacterium tuberculosis, mice were housed under
barrier conditions in the ABSL-3 facility at NYUMC. All mice used were
females, between 8 and 12 weeks of age at the beginning of the experiment.
For tissue harvest, mice were euthanized by CO2 asphyxiation followed by
cervical dislocation. All experiments were performed with the prior approval
of NYUMC Institutional Animal Care and Use Committee.
Generation of Bone Marrow Chimeras
Donor wild-type and Ifngr1/ mice were euthanized with CO2 asphyxiation
and cervical dislocation, and femurs and tibias were removed aseptically.
Bone marrow was flushed with cold DMEM (Invitrogen), supplemented with
10% heat-inactivated FCS (Invitrogen) and 2 mM L-glutamine (Invitrogen).
Cells were washed twice with PBS without calcium and magnesium (Invitro-
gen), supplemented with 1% FCS. The suspension was depleted of mature
T cells by treatment with microbeads coated with anti-Thy1.2 antibody (Milte-
nyi Biotec) followed by magnetic-activated cell sorting according to the
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eter with a Trypan blue exclusion assay. Recipient wild-type and Ifngr1/
mice were irradiated with 10 Gy in split doses at 2 hr intervals. They were re-
constituted no later than 6 hr after the last irradiation with 2 3 106 wild-type
(W/W and W/K mice) or Ifngr1/ (K/W and K/K mice) cells by intrave-
nous injection. Mice were given sulfamethoxazole (150 mg/ml) and trimetho-
prim (30 mg/ml) in drinking water for the first 3 weeks of reconstitution.
Chimeras were used no earlier than 6 weeks after transplantation. Prior to
infection withM. tuberculosis, we confirmed that mice reconstituted with con-
genic bone marrow stem cells had achieved a satisfactory level of chimerism
by assessing the number of CD45.1+ (wild-type) and CD45.2+ (Ifngr1/)
leukocytes in the lungs, using flow cytometry (Figure S1). In this organ, the
proportion of donor-derived leukocytes averaged 86.6% ± 1% over multiple
experiments, after the transfer of either wild-type or Ifngr1/ marrow, and
did not vary over time after M. tuberculosis infection. The same result was
found in the spleen (data not shown).
Bacterial Infection
The H37Rv strain of Mycobacterium tuberculosis was grown as previously
described (Banaiee et al., 2006). Chimeras were infected via the aerosol route,
with an inhalation exposure system (Glas-Col) (Wolf et al., 2007), calibrated to
deliver 150 colony-forming units (CFUs) per animal. The infectious dose was
confirmed on day 1 by plating whole-lung homogenates from 5 sentinel
mice on Middlebrook 7H11 agar. CFU were counted after incubation at
37C for 2–3 weeks. To determine the bacterial load throughout the infection,
we harvested the right lung, MLN, and spleen from chimeric mice, homoge-
nized them and plated serial dilutions on Middlebrook 7H11 agar.
Histology and Immunohistochemistry
The left lung was excised, fixed in 4% paraformaldehyde (PFA) for 1 week at
room temperature, and embedded in paraffin. Sections of 5 mm were cut
and stained with hematoxylin and eosin. Alternatively, sections were treated
with an acid-fast Kinyoun’s stain to reveal the presence of M. tuberculosis
and counterstained with Brilliant Green.
For indoleamine 2,3-deoxygenase (IDO) immunostaining, PFA-fixed,
paraffin-embedded lung sections were deparaffinized with CitriSolv solution
(Fisher Scientific) and rehydrated by successive baths of decreasing ethanol
concentration. Endogenous peroxidase activity was blocked by treatment
with 3%H2O2. Endogenous avidin/biotin activity was blocked with a commer-
cially available kit (Vector Laboratories). Nonspecific binding sites were
saturated by a solution of bovine serum albumin 2%. IDO was stained with
a polyclonal rabbit anti-murine IDO antibody (Alexis Biochemicals). Subse-
quently, the sections were incubated with biotinylated polyclonal goat
anti-rabbit IgG, streptavidin-conjugated horseradish peroxidase and DAB
chromogenic substrate (Vector Laboratories). The tissues were counter-
stained with hematoxylin, dehydrated, and mounted with PerMount solution
(Fisher Scientific).
Cell Isolation and Flow Cytometry
The right lung aswell as theMLNwere removed and processed for flow cytom-
etry as previously described (Wolf et al., 2007). Antibodies conjugated to
various fluorophores and directed against the following surface markers
were used: CD4 (RM4-5, BioLegend), CD8a (53-6.7, BD Biosciences),
CD62L (MEL-14, BioLegend), CD45RA (14.8, BioLegend), Dx5 (BD Biosci-
ences), B220 (RA3-6B2, BD Biosciences), CD19 (6D5, BioLegend), CD11c
(HL3, BD Biosciences), CD11b (M1/70, BD Biosciences), Gr-1 (RB6-8C5, BD
Biosciences), and CD45.2 (104, BD Biosciences) A minimum of 200,000
events per sample, gated on live cells with forward and side scatter parame-
ters, was acquired with an LSRII and the FACSDiva software (BDBiosciences).
Data were analyzed with the FlowJo software (TreeStar).
Microarray Analysis
Total RNA was extracted from the left lung with TriZol reagent (Invitrogen) and
was processed as previously described for removal of contaminating genomic
DNA and reverse transcription (Banaiee et al., 2006). RNA integrity of individual
samples was confirmed by ribosomal RNA profiles at the Genomics Facility of
the Cancer Institute of NYU Langone Medical Center. RNA samples of each
group of mice were pooled and the resulting pools were hybridized againstIeach other for differential gene expression analysis with Agilent Whole Mouse
Genome Oligo Microarray (Miltenyi Biotec). Microarray data are available from
the National Center for Biotechnology Information Gene Expression Omnibus
(NCBI-GEO) database under accession number GSE19148.Real-Time Quantitative RT-PCR
Total RNA was extracted from lung tissues as described above. The cDNA
equivalent of 50 ng of total RNA was analyzed for specific gene expression in
triplicate for each sample by quantitative real-time PCR with Platinum SYBR
Green qPCR SuperMix (Invitrogen) on an MJ Research Opticon 2. Sequences
of the primer pairs can be found in Table S1. Thermal cycling conditions were
95C for 10 min then 40 cycles at 94C for 45 s, 58C for 30 s, and 72C for
30 s. For quantitation, the relative values were determined by comparing the
threshold cycle C(t) of each sample to a standard curve consisting of serial dilu-
tions of a positive control cDNA sample. Results were normalized with 18S
rRNA expression as an internal standard for each sample.Cell Culture and Inhibition Studies
For the in vitro differentiation of Th17 cells, CD4+ T cells were isolated from
spleen and lymph nodes of C57BL/6 mice followed by magnetic cell sorting
using anti-CD4+ antibody-coated microbeads (Miltenyi Biotec). Cells were
resuspended in RPMI supplemented with 10% FBS, hamster anti-murine
CD3 antibody (0.25 mg/ml), hamster anti-murine CD28 antibody (1 mg/ml),
anti-murine IL-4 neutralizing antibody (1 mg/ml), anti-murine IFN-g neutralizing
antibody (1 mg/ml), recombinant murine IL-6 (20 ng/ml, PeproTech), recombi-
nant human TGFb (0.5 mg/ml, PeproTech), and recombinant murine IL-23
(20 ng/ml, eBioscience). All antibodies were purchased from BioLegend. The
cells were seeded at a density of 105 cells/well in 96-well plates precoated
with 0.12 mg/ml of goat anti-hamster IgG antibody (Vector Laboratories) and
cultured for 6 days at 37C in 5%CO2. In some experiments, IL-23was omitted
or only added on the third day of culture. The concentration of IL-17 in culture
supernatants was measured by ELISA (R&D Systems).
For comparison studieswith Th1 cells, T cells were differentiated in the same
in vitro conditions, with only anti-murine IL-4 neutralizing antibody, recombi-
nant murine IL-2 (10 ng/ml, eBioscience), and recombinant murine IL-12p70
(20 ng/ml, BD Biosciences) and CD3/CD28 stimulation. The concentration of
IFN-g in culture supernatants was measured by ELISA (BD Biosciences).
L-kynurenine, 30-hydroxy-DL-kynurenine, 30-hydroxyanthranilic acid,
anthranilic acid, and quinolinic acid (Sigma) were dissolved in RPMI medium
under agitation at 1 mM concentration and sterile filtered. Tryptophan catab-
olites were added individually or in combination, in 2-fold dilutions, to the
differentiating medium of Th1 or Th17 cells for the 6 days of culture.Statistical Analysis
Results are expressed as mean and standard error. Student’s two-tailed t test
was used for comparing experimental groups, unless otherwise stated, with
p < 0.05 considered significant.SUPPLEMENTAL DATA
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